3D optical/CT as a preclinical companion imaging platform for glioblastoma drug development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

3D optical/CT as a preclinical companion imaging platform for glioblastoma drug development

Published:2020-01-01 Issue:1 Volume:27 Page:1686-1694
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Molotkov Andrei¹,Doubrovin Mikhail¹,Bhatt Nikunj¹,Hsu Fang-Chi²,Beserra Amanda³^ORCID,Chopra Rajiv³^ORCID,Mintz Akiva¹

Affiliation:

1. Columbia University PET Center, Department of Radiology, Columbia University Medical Center, New York, NY, USA

2. Department of Biostatistics and Data Science, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA

3. Department of Radiology and Advanced Imaging Research Center, UT Southwestern Medical Center, Dallas, TX, USA

Funder

National Center for Advancing Translational Sciences

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2020.1833381

Reference41 articles.

1. Structure and function of the blood–brain barrier

2. Focused Ultrasound Delivers Targeted Immune Cells to Metastatic Brain Tumors

3. Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood–tumor barrier disruption

4. Blood-brain barrier disruption in immature Fischer 344 rats

5. Clinical trial of blood-brain barrier disruption by pulsed ultrasound

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatial multiplexing and omics;Nature Reviews Methods Primers;2024-08-01

2. A clinically relevant computed tomography (CT) radiomics strategy for intracranial rodent brain tumour monitoring;Scientific Reports;2024-02-01

3. Obstacles to Glioblastoma Treatment Two Decades after Temozolomide;Cancers;2022-06-30

4. ImmunoPET: Antibody-Based PET Imaging in Solid Tumors;Frontiers in Medicine;2022-06-28

5. Characterization methodologies for long-acting and implantable drug delivery systems;Long-Acting Drug Delivery Systems;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3